Thus, the heterozygous mutation in exon 12 could be responsible for latent SGLT2 hypofunction, and the underlying UCTD-associated autoimmunity could have induced the manifestation of its hypofunction. The gene discussed is SLC5A2; the disease is Autoimmunity.